Development of a membrane lipid metabolism –based signature to predict overall survival for personalized medicine in ccRCC patients
ConclusionOur study might contribute to the optimization of risk stratification for survival and personalized management of ccRCC patients.
Source: EPMA Journal - Category: International Medicine & Public Health Source Type: research
More News: Cancer & Oncology | Carcinoma | Genetics | International Medicine & Public Health | Kidney Cancer | Renal Cell Carcinoma | Study